甲状腺功能低下症对糖尿病及其微血管并发症风险的影响:孟德尔的随机化研究
Ting Fang1,2, Xiaoqing Deng1,2, Jingyi Wang1,2
1NHC Key Laboratory of Hormones and Development, Tianjin Medical University Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Frontiers in endocrinology
|December 20, 2023
概括
甲状腺功能低下会导致1型糖尿病及其并发症,包括脏问题和特定类型的糖尿病视网膜病变. 这项研究澄清了甲状腺功能低下症和糖尿病微血管并发症之间的因果关系.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
- 眼科医生 眼科 眼科
背景情况:
- 观察性研究表明甲状腺功能低下症和糖尿病微血管并发症之间的联系.
- 甲状腺功能低下症和糖尿病之间的因果关系尚不清楚.
研究的目的:
- 用孟德尔随机化研究甲状腺功能低下对糖尿病及其微血管并发症的因果关系.
主要方法:
- 进行了一项双样本的门德尔随机化研究.
- 甲状腺功能低下症的总结统计数据来自英国生物银行.
- 利用了糖尿病和并发症的全基因组关联研究数据.
主要成果:
- 甲状腺功能低下症与1型糖尿病和1型糖尿病与脏并发症因果相关.
- 在甲状腺功能低下症和严重的非增殖性糖尿病视网膜病变和增殖性糖尿病视网膜病变之间发现了积极的关联.
结论:
- 甲状腺功能低下症在1型糖尿病的发展中起着因果作用.
- 甲状腺功能低下症与糖尿病的特定微血管并发症有关,包括脏疾病和视网膜病变.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Pathophysiology of Diabetes
944
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
944
Oral Hypoglycemic Agents: Biguanides and Glitazones
207
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
207
Diabetes: Symptoms, Diagnosis, and Complications
553
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
553
Diabetes: Management and Pharmacotherapy
288
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
288


